This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Stay vigilant for fake initial coin offerings by examining whitepapers, token metrics, and regulatory disclosures to prevent losses.
17,900 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
A private investment strategy disclosed a $100 million Bitcoin buy funded by a stock sale, boosting its BTC reserves ...
President Trump urged the Fed to cut rates immediately, sending ripples through cryptocurrency markets as traders pri...
An AI model branded as WarrenAI outlines a bifurcated Bitcoin path for late 2026: a resilient floor around $50k-$55k ...
A leading analyst warns of multi-year shortages coming optical as AI data-center growth strains suppliers. LUMENTUM a...
The U.S. government has halted Anthropic's Fable 5 and Mythos 5, citing a security vulnerability. The move shakes fin...
Two high-yield closed-end funds are sparking debate as one slashes distributions and the other maintains payments. He...
SpaceX's post-IPO moves could ripple through the market. This guide explains what to watch, how to react, and smart s...
General Mills sits near $39 after a soft quarter, boosting the dividend to about 6.3%. Retirees eyeing general mills’...
Bitcoin’s iran rally faces a fresh test as macro signals from oil, equities, and Japanese policy converge. Markets we...
Bitcoin sits roughly 43% below its all-time high as macro headwinds and fund outflows weigh on sentiment. This report...
A Friday move by the U.S. to restrict access to Anthropic’s Mythos model triggers a global push for sovereign AI and ...